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Abstract 
 
Background: Several studies have shown that non-adherence is a common and increasing problem 
regarding those with chronic illnesses, including chronic kidney disease (CKD) patients undergoing 
hemodialysis (HD).  
Objective: The present study aimed to investigate the influence of sociodemographic features as well 
as beliefs about medicines on adherence to medication treatment among HD patients.  
Methodology: A sample of 168 individuals was recruited from six General Hospitals in the broader 
area of Athens, consisting of patients undergoing in - centre HD. Measurements were conducted with 
the following instruments: the Medication  Adherence  Rating  Scale (MARS) and the Beliefs about 
Medicines Questionnaire (BMQ).  
Results: Medication adherence was associated positively with family (r= 0.24, p= 0.00) and work 
status (r= 0.26, p= 0.00) as well as BMQ - concern (r= 0.19, p= 0.02).  
Conclusions: The present study demonstrates the importance of sociodemographic characteristics in 
understanding  medication  adherence  in  HD  patients  as  well  as  the  contribution  of  beliefs  about 
medicines. 
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Introduction 
 
Patients  suffering  from  Chronic  Kidney 
Disease  (CKD)  have  to  cope  with  many 
adversities,  e.g.  physical  symptoms, 
limitations in food and fluid intake, changes 
in  their  body  image,  work  and  economic 
status,  social  roles,  activity  levels,  self  - 
image,  health  status  and  normal  routines, 
while  their  control  over  treatment  cannot 
always  be  predicted  (Mavromates,  2005; 
Theofilou, 2011; Theofilou, 2012; Theofilou, 
2012a;  Theofilou,  in  press;  Theofilou, 
Synodinou & Panagiotaki, in press a). Such 
constraints  are  expected  to  affect  the 
patients’ life and physical as well as social 
functioning, leading them to reconsider their 
personal  and  professional  goals  within  the 
context  of  living  with  a  chronic  illness 
(Mavromates,  2005;  Theofilou,  2011a; 
Theofilou,  2012;  Theofilou,  2012a; 
Theofilou, in press; Theofilou et al., in press 
a).  
Effective  CKD  control  requires  regular 
preventive medication and a response to that 
medication.  Poor  receptiveness  to  CKD 
medication  can  be  related  to  individual 
variability  in  the  dose  needed to achieve a 
response,  as  well  as  to  low-adherent 
behaviour in relation to the CKD medication 
regimen.  In  a  systematic  review  of  19 
studies,  which  evaluated  medication 
adherence among patients receiving dialysis, 
rates of medication non-adherence (evaluated 
with  self-report,  structured  interview  and 
predialysis serum phosphorus levels) ranged 
from  3%  to  80%  (mean  67%)  (Schmid, 
Hartmann & Schifl, 2009).  
The  concept  of  adherence  has  been 
developed from the concept of compliance, 
but  opinions  about  the  definitions  of 
adherence  and  compliance  differ  (Horne, 
2006).  Compliance  and  adherence  can  be 
viewed as synonyms or as different concepts 
(Haynes, Ackloo, Sahota, McDonald & Yao, 
2005).  The  increased  use  of  the  term 
adherence  may  be  due  to  the  sometimes 
passive  and  controlling  undertone  in  the 
concept  of  compliance.  Adherence 
emphasises the need for agreement and can International   Journal  of   Caring   Sciences  2013   May – August  Vol 6  Issue 2 
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be  defined  as  the  extent  to  which  the 
patient’s  behaviour  matches  the  agreed 
recommendations from the prescriber and the 
prescription  (World  Health  Organization, 
2003).  
Many factors have been found to influence 
medication  adherence,  and  those associated 
with  non-adherent  behaviour  can  be 
organised  into  five  interacting  domains: 
socioeconomic  factors;  therapy-related 
factors;  patient-related  factors;  condition-
related  factors;  and  health  care  system 
factors  (Bame,  Petersen  &  Wray,  1993; 
Christensen & Smith, 1995; Leggat, Orzol, 
Hulbert-Shearon  et  al.,  1998;  Kammerer, 
Garry,  Hartigan,  Carter  &  Erlich,  2007; 
Russell,  Knowles  &  Peace,  2007).  In  the 
present study, the focus is on patient-related 
factors - i.e., gender, age, education as well 
as beliefs about medicines. 
In  patients  with  chronic  illness  and  CKD, 
adherence to medication regimens has been 
found  to  correlate  with  beliefs  about 
medicines  (Horne  &  Weinman,  1999).  A 
theoretical framework has been developed to 
explain  how  beliefs  about  medicine  can 
influence  patients’  decisions  about  taking 
medicines  (Horne,  1997).  Adherent 
behaviour  is  likely  to  be  associated  with 
personal beliefs about the specific prescribed 
medication. Beliefs about the necessity of the 
medication  for  controlling  illness  are 
balanced against concerns about the possible 
negative  effects  of  medication  (Horne, 
Weinman  &  Hankins,  1999).  Adherent 
behaviour  depends  on  which  of  the  two 
predominates - beliefs in the necessity of the 
medication  or  concerns  about  possible 
danger (Horne & Weinman, 1999). 
The  purpose  of  this  study  is  to  determine 
which  sociodemographic  and  psychological 
factors  contribute  to  medication  adherence 
by CKD patients.  
 
Method 
 
Participants 
 
A sample of 168 patients was recruited from 
six General Hospitals in the broader area of 
Athens, undergoing in - centre hemodialysis 
(HD). Selection criteria included: 
1.  > 18 years of age 
2.  Ability of communication in Greek 
3.  Diagnosed with CKD 
4.  Dialysis  treatment  at  least  for  a 
year 
5.  Satisfying level of cooperation and 
perceived ability  
The rate of response was very high, reaching 
99%. Thus, the total sample includes almost 
all patients of these six units, consisting of 
105 males (62.5%) and 63 females (37.5%), 
with  a  mean  age  of  62.4  years  ±  13.5. 
Participants were Greek adults having signed 
a consent form for participation. All subjects 
had been informed of their rights to refuse or 
discontinue  participation  in  the  study 
according  to  the  ethical  standards  of  the 
Helsinki Declaration. Ethical permission for 
the  study  was  obtained  from  the  scientific 
committees  of  the  participating  hospitals. 
Full  descriptive  data  of  the  sample  are 
presented in table 1.  
 
Procedure 
Measurements  were  conducted  with  the 
following instruments: 
1)  The  inventory  Medication  Adherence 
Report Scale (MARS) is a 5-item self-report 
scale  for  assessment  of  non-adherent 
behaviour (e.g., ‘I forgot to take them’ and ‘I 
alter the dose’). The items are rated on a 5-
point Likert scale, ranging from 1 = ‘always’ 
to 5= ‘never’ (range 5 to 25). Lower scores 
indicate lower levels of adherent behaviour 
(Horne & Hankins, 2004).  
2)  The  Beliefs  about  Medicines 
Questionnaire (BMQ) consists of two five-
item scales assessing patients’ beliefs about 
the  necessity  of  prescribed  medication  for 
controlling  their  disease and  their  concerns 
about  potential  adverse  consequences  of 
taking it. Respondents indicate their degree 
of agreement with each statement on a five-
point Likert scale, ranging from 1 = strongly 
disagree  to  5  =  strongly  agree.  Scores 
obtained  for  individual  items  within  both 
scales are summed.  
Thus,  total  scores  for  the  Necessity  and 
Concerns Scales range from 5 to 25. Higher 
scores indicate stronger beliefs (Horne et al., 
1999). A necessity - concerns differential is 
calculated  as  the  difference  between  the 
necessity  and  the  concerns  scales,  with  a 
possible  range  of  -20  to  +20.  This 
differential can be thought of as the cost - 
benefit analysis for each patient, for whom International   Journal  of   Caring   Sciences  2013   May – August  Vol 6  Issue 2 
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costs  (concerns)  are  weighed  against  their 
perceived benefits (necessity beliefs) (Horne 
et al., 1999).  
 
Statistical analysis 
 
Kolmogorov  - Smirnov test was performed 
in order to check whether the values of the 
sample  would  fall  within  a  normal 
distribution.  Next,  the  analyses  performed 
aimed  to  investigate  the  relation  between 
medication adherence and sociodemographic 
variables as well as beliefs about medicines. 
Thus,  correlation  analysis  was  performed 
using Pearson’s rho. Hierarchical regression 
analyses were also used to assess the above 
association. Initially, simple correlation was 
examined  among  variables  referring  to 
medication  adherence,  sociodemographic 
features and beliefs about medicines in HD 
patients. Further, a regression analysis model 
was constructed using medication adherence 
as dependent variable. Independent variables 
included sociodemographic characteristics as 
well  as  medication  beliefs.  A  p  -  value  of 
0.05  or  less  was  considered  to  indicate 
statistical  significance.  The  nominal 
variables of gender, education, marital status 
and work status, in order to be included in 
the  analyses,  were  recoded  in  the  below 
categories:  
a.  Gender (males, value 1), (females, value 
2) 
b.  Education  (primary,  value  1), 
(secondary,  value  2),  (university,  value 
3) 
c.  Marital status (single, value 1), (married, 
value 2), (divorced, value 3), (widowed, 
value 4) 
d.  Work  status  (employee,  value  1), 
(freelancer, value 2), (households, value 
3), (pensioner, value 4) 
All  analyses  were  performed  with  the 
Statistical  Package  for  the  Social  Sciences 
(SPSS 13.0 for Windows). 
 
Results 
 
The values of the total cohort were found to 
pass the normality distribution test.   
 
 
 
Investigating  the  relation  between 
medication adherence and sociodempgraphic 
variables as well as beliefs about medicines, 
medication  adherence  was  associated 
positively with family (r= 0.24, p= 0.00) and 
work status (r= 0.26, p= 0.00) and BMQ - 
concern scale (r= 0.19, p= 0.02) (table 2).  
A  hierarchical regression analysis  was also 
performed  in  order  to  investigate  the  afore 
mentioned association in the total sample of 
HD patients.  
Specifically, the variables of gender and age 
were  found  to  have  a  negative  effect  on 
patients’ medication adherence.  
On the other hand, work status was found to 
have  a  positive  effect.  Regarding  beliefs 
about medicines, BMQ - necessity scale was 
related  in  a  negative  way  to  medication 
adherence while BMQ - concern scale was 
related positively (table 3).  
 
Discussion 
 
The present study shows strong associations 
of  medication  adherence  with 
sociodemographic factors as well as beliefs 
about medicines in CKD patients.  
Regarding  the  relation  between 
sociodemographic  dimensions  and  the 
variable of medication adherence in the total 
sample, it seems that gender, age, marital and 
work  status  are  predictors  of  adherence  to 
medication treatment.  
As far as gender is concerned, the results of 
this  study  correspond  to  previous  studies 
showing that higher prevalence of adherence 
is  observed  among  men  (Ciechanowski, 
Katon,  Russo  &  Walker,  2001;  Barsky, 
Peekna  &  Borus,  2001;  Jiang,  Hasselblad, 
Krishnan  &  O’connor,  2002;  Barnes,  Gott, 
Payne, Parker, Seamark, Gariballa & Small, 
2006;  Evangelista,  Moser,Westlake,  Pike, 
Ter Galstanyan & Dracup, 2008; Holzapfel, 
Muller-Tasch,  Wild,  Junger,  Zugck, 
Remppis, Herzog & Lowe, 2008).  
This  finding  could  be  explained  by  the 
fact that women are more prone to stress 
and to develop mental health conditions.International   Journal  of   Caring   Sciences  2013   May – August  Vol 6  Issue 2 
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Table 2. Correlations between sociodemographic variables, beliefs about medicines and medication adherence in the total sample. 
  Sociodemographic variables  BMQ scales 
MARS  Gender  Age  Education  Family status  Work status  BMQ - necessity  BMQ - concern 
 
Medication 
adherence 
0.15  0.09  0.08  0.25   0.26   -0.12  0.19  
 
MARS, Medication Adherence Rating Scale; BMQ, Beliefs about Medicines Questionnaire  
**p<0.01; *p<0.05; N=168. 
 
Table 3. Hierarchical Regression Analysis: sociodemographic 
variables and beliefs about medicines affecting medication 
adherence in the total sample. 
 
Dependent 
Variable 
 
Independent 
variables 
Beta  p-value 
Medication 
adherence 
Gender  -0.19  0.03* 
  Age  -0.23  0.02 
  Education  0.07  0.38 
  Family status  0.00  0.96 
  Work status  0.60  0.00 
  BMQ - necessity  -0.48  0.00 
  BMQ - concern  0.51  0.00 
 
BMQ, Beliefs about Medicines Questionnaire 
**p<0.01; *p<0.05; N=168. International   Journal  of   Caring   Sciences  2013   May – August  Vol 6  Issue 2 
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Thus, emotional disorders like depression can 
be  associated  with  non  -  adherence  to  drug 
therapy  (Stilley,  Sereika,  Muldoon,  Ryan  & 
Dunbar-Jacob,  2004;  Bosworth,  Voils,  Potter 
&  Steffens,  2008;  Julian,  Yelin,  Yazdany, 
Panopalis,  Trupin,  Criswell  &  Katz,  2009; 
Gimenes  -  Turcatto,  Zanetti  &  Haas  -
 
Vanderlei,  2009;  Song,  Moser  &  Lennie, 
2009).  Regarding  age,  findings  are 
controversial.  Specifically,  while  some 
investigators have found older patients to have 
better  adherence,  others  have  shown  younger 
patients  to  be  more  successful  adherers 
(Granger,  Ekman,  Granger,  Ostergren, 
Olofsson,  Michelson,  McMurray,  Yusuf  S, 
Pfeffer  &  Swedberg,  2009).  Monane  et  al. 
(1994) and Evangelista et al. (2003) found old 
age to be independently associated with better 
adherence, and reported that older participants 
(.85  and  .65  years  old,  respectively)  had  ‘no 
difficulty’  in  adhering  to  medications  when 
compared with younger patients. In contrast, in 
a study of heart failure patients over 85 years 
of  age,  DeGeest  et  al.  (2003)  found  that  the 
elderly  were  less  able  to  perform  self  care 
behaviours  and  were  less  adherent  to  a 
medication  regimen.  In  our  study  younger 
patients  are  presented  more  adherent  in 
comparison  to  older  patients.  This  could  be 
explained by the fact that in advanced age the 
use of amount of pills is greater than in youth, 
causing in this way non – adherence (Magacho, 
Ribeiro, Chaoubah & Bastos, 2011). Moreira et 
al. (2008) observed that the average number of 
daily pills (≥4 pills per day) in older patients 
and  the  more  advanced  stages  of  CKD  were 
statistically  associated  with  non-adherence  to 
drug therapy. 
Concerning  marital  status,  patients  who  are 
widowed  seem  to  adhere  better  than  the 
married,  singles  and  the  divorced.  This  is  a 
finding  which  is  in  agreement  with  other 
studies’ results (Adisa, Fakeye & Fasanmade, 
2011).  
In contrast to the results of this study, in the 
literature  widowhood  is  associated  with  a 
higher rate of voluntary dialysis withdrawal as 
well  as  a  lower  quality  of  life  (Mavromates, 
2005;  Theofilou,  2012;  Theofilou,  2012a; 
Theofilou, in press; Theofilou et al., in press a). 
Further,  the  finding  that  pensioners  and 
housewives  are  more  adherent  to  medication 
treatment is similar to other studies elsewhere 
(Talam,  Gatongi,  Rotich  &  Kimaiyo,  2008). 
The results established that being away  from 
home  contributed  to  poor  timing  of  taking 
drugs among the patients. Several studies have 
shown that being away from home, being too 
busy  and  forgetting  are  closely  interrelated 
(Platt,  Tippy  &  Turk,  1994;  Orrell  &  Word, 
2001).  Studies  elsewhere  have  shown  that 
chronic  disease  patients,  like  HIV/AIDS 
patients,  have  difficulties  in  taking  drugs  in 
public  and  carrying  drugs  around  thereby 
adversely  affecting  adherence  (Grierson, 
Bartos, De Visser & McDonald, 2000). Factors 
that were found to be significantly associated 
with  poor  adherence  among  HIV/AIDS 
patients was time of working (χ2= 6.2180, p= 
0.013).  This  implied  that  busy  working 
schedules  contributed  to  poor  adherence  to 
medications  (Grierson,  Bartos,  De  Visser  & 
McDonald,  2000).  It  was  also  found  that  87 
(57.4%) of females and 36 (61.0%) of males 
who  had  secondary  or  post  secondary 
education  failed  to  take  drugs  on  time 
scheduled.  This  implied  that  patients  with 
higher  education  were  most  likely  busy  with 
their  professional  activities.  Due  to  their 
professional status in the society it could have 
been difficult for them to go for drug refills and 
to take medication in public (Grierson, Bartos, 
De Visser & McDonald, 2000). 
As far as beliefs about medicines is concerned, 
the present study indicates that CKD patients 
who are presented more adherent to medication 
treatment  have  lower  scores  on  the  BMQ  - 
necessity scale and higher scores on the BMQ - 
concern scale. Further investigation is needed 
regarding  this  point  because  earlier  studies 
have shown that when beliefs in the necessity 
of medication are stronger than concerns, the 
adherent  behaviour  will  increase  (Emilssona, 
Berndtssona,  Lftvallb,  Millqvistb,  Lundgrenc, 
Johanssond  &  Brinke,  2011).  The  most 
adherent individuals are those who accept the 
necessity of medication and have low concerns 
about  potential  adverse  consequences 
(Menckeberg, Bouvy & Bracke, 2008; Tibaldi, 
Clatworthy,  Torchio,  Argentero,  Munizza  & 
Horne, 2009). Horne, Cooper, Gellaitry, Date, 
and  Fisher  (2007)  conducted  similar  research 
among  patients  recruited  from  an  outpatient 
HIV  clinic  who  were  debating  whether  to 
accept or decline initiation of HAART (highly 
active  retroviral  therapy)  pharmacotherapy 
(Horne,  PharmS,  Cooper,  Gellaitry,  Date, 
PharmS & Fisher, 2007). Those who declined 
HAART  had  low  scores  on  the  BMQ  - 
necessity scale and high scores on the BMQ - International   Journal  of   Caring   Sciences  2013   May – August  Vol 6  Issue 2 
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concern scale. This study was unique in that it 
was  a  longitudinal  study  and  patients  were 
contacted  at  12  months  after  baseline.  At 
follow-up,  HIV  patients  who  had  scored  low 
on  the  necessity  scale  and  high  on  the26 
concern  scale  at  baseline  reported  low 
adherence 12 months later (Horne et al., 2007).  
Limitations in our study warrant mention. First, 
there  is  a  need  for  future  research  to  use 
prospective  and  longitudinal  study  designs  to 
examine  the  interaction  between  adherence 
with  medication  and  sociodemographic 
features as well as beliefs about medicines in 
patients with CKD.  
Another  methodological  issue  relates  to  the 
sample  representativeness.  Studies  on  the 
broader  CKD  population  and  recruiting  even 
larger samples to enable effective multi-group 
analysis should be pursued in future research. 
Further,  measuring  medication  adherence  in 
the  CKD  population  can  be  impacted  by 
numerous  other  factors  besides  medications 
(such as adherence to diet or fluid intake and 
dialysis), residual renal function, dialytic age, 
comorbid conditions, nutritional status or type 
of dialysis treatment and cognitive impairment. 
In future studies, the above variables should be 
examined  using  in  this  way  consistent  and 
standardized measures of compliance.  
Also, medication adherence can be affected by 
personality traits. According to McCrae’s and 
Costa’s  “Model  of  the  person”,  personality 
traits  (understood  as  underlying  tendencies) 
may explain a person’s thoughts, feelings and 
actions.  The  association  between  personality 
traits and medication adherence may therefore 
be indirect - i.e., the associations between these 
characteristics and beliefs about medicines may 
be  of  importance  to  adherent  behaviour.  The 
impact  of  personality  traits  on  beliefs  about 
medicines  as  well  as  on  treatment  adherence 
could be investigated in this study. Perhaps, the 
possible correlations may explain the relations 
that were found between BMQ scales and CKD 
medication treatment.  
Despite  its  limitations,  the  present  study 
demonstrates  the  significance  of 
sociodemographic and psychological factors in 
understanding  medication  adherence  of 
patients  with  CKD.  It  is  important  for  renal 
health professionals to identify and attempt to 
remove  their  patients’  barriers  to  medication 
self-management  and  optimal  medication 
adherence. Staff in the dialysis unit can impact 
patient  satisfaction  with  care  and  include 
patients  as  active  team  members  in  order  to 
identify barriers to  medication adherence and 
to create individualized care plans for patients. 
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